NDC 17156-235

AdreView

Iobenguane I-123

AdreView is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Medi-physics Inc.. The primary component is Iobenguane I-123.

• Product ID: 17156-235_0b572d19-1394-4123-9c7b-0b7cbfc5c79d
• NDC: 17156-235
• Product Type: Human Prescription Drug
• Proprietary Name: AdreView
• Generic Name: Iobenguane I-123
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2008-09-19
• Marketing Category: NDA / NDA
• Application Number: NDA022290
• Labeler Name: Medi-Physics Inc.
• Substance Name: IOBENGUANE I-123
• Active Ingredient Strength: 2 mCi/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 17156-235-01

1 VIAL, GLASS in 1 CONTAINER (17156-235-01) > 5 mL in 1 VIAL, GLASS

• Marketing Start Date: 2008-09-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 17156-235-01 [17156023501]

AdreView INJECTION

• Marketing Category: NDA
• Application Number: NDA022290
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2008-09-19

Drug Details

Active Ingredients

Ingredient	Strength
IOBENGUANE I-123	2 mCi/mL

OpenFDA Data

• SPL SET ID: c89d3ecc-4f4c-4566-8808-79152344194d
• Manufacturer:
  • Medi-Physics Inc.
• UNII:
  • P2TH1XYZ84